For those exploring this path, regular communication with a healthcare team is critical
Because retatrutide slows gastric emptying (as do other agents in this class), it may theoretically affect the absorption rate of orally administered medicines
Lawsuits highlight the long-term risks of GLP-1 medications, with patients reporting complications that affect digestion and vital organs, as well as overall health
The TRIUMPH-1 trial's fascinating outcomes for Retatrutide hint at enhanced weight loss potential, especially compared to tirzepatide's SURMOUNT-1 trial reports
The Bottom Line Foundayo (orforglipron) is a real, FDA-approved oral GLP-1 medication that eliminates the injection and fasting barriers that have kept many eligible patients from starting GLP-1 therapy
While Eli Lilly has traditionally invested more in R&D, its recent surge in buybacks and dividends signals a growing focus on investor returns